Nov 7 (Reuters) - Invion Ltd (IVX) :
- INVION COLLABORATES TO DEVELOP POWERFUL SKIN CANCER GEL
- COMPANY AIMS TO HAVE IVX-P02 GEL READY IN EARLY 2019 FOR TESTING IN HUMAN CLINICAL STUDIES
- PARTNERED WITH TWO COMPANIES TO FORMULATE AND TEST A GEL VERSION OF ITS PHOTOSENSITISER PRODUCT, IVX-P02
- DEVELOPMENT OF INJECTABLE IVX-P02 PHOTOSENSITISER IS ALSO PLANNED FOR TESTING IN SOLID CANCERS SUCH AS OVARIAN, PROSTATE AND LUNG CANCER
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.43M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.5¢ | $4.833K | 35.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24920 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 36207 | 3 |
View Market Depth
| Last trade - 13.25pm 18/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |